Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of Epidermal Growth Factor Receptor and Programmed Death Ligand 1 Testing in a Population-Based Lung Cancer Surgical Resection Cohort from 2018 to 2022.
Smeltzer MP, Akinbobola OA, Ray MA, Fehnel C, Saulsberry A, Dortch KR, Pimenta K, Matthews AT, Osarogiagbon RU. Smeltzer MP, et al. Among authors: akinbobola oa. Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):1098-1106. doi: 10.1158/1055-9965.EPI-23-1401. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38884583
In Response: Taichiro Goto "Kit Use May Not Be Key To Improved Prognosis"; Response to "Akinbobola O, Ray MA, Fehnel C, et al. Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit".
Akinbobola O, Ray MA, Smeltzer MP, Osarogiagbon RU. Akinbobola O, et al. J Thorac Oncol. 2023 Aug;18(8):e80-e81. doi: 10.1016/j.jtho.2023.05.017. J Thorac Oncol. 2023. PMID: 37479331 Free article. No abstract available.
Surgeon Quality and Patient Survival After Resection for Non-Small-Cell Lung Cancer.
Ray MA, Akinbobola O, Fehnel C, Saulsberry A, Dortch K, Wolf B, Valaulikar G, Patel HD, Ng T, Robbins T, Smeltzer MP, Faris NR, Osarogiagbon RU; Mid-South Quality of Surgical Resection (MS-QSR) Consortium. Ray MA, et al. Among authors: akinbobola o. J Clin Oncol. 2023 Jul 10;41(20):3616-3628. doi: 10.1200/JCO.22.01971. Epub 2023 Jun 2. J Clin Oncol. 2023. PMID: 37267506 Free PMC article.
Lung Cancer Diagnosed Through Screening, Lung Nodule, and Neither Program: A Prospective Observational Study of the Detecting Early Lung Cancer (DELUGE) in the Mississippi Delta Cohort.
Osarogiagbon RU, Liao W, Faris NR, Meadows-Taylor M, Fehnel C, Lane J, Williams SC, Patel AA, Akinbobola OA, Pacheco A, Epperson A, Luttrell J, McCoy D, McHugh L, Signore R, Bishop AM, Tonkin K, Optican R, Wright J, Robbins T, Ray MA, Smeltzer MP. Osarogiagbon RU, et al. Among authors: akinbobola oa. J Clin Oncol. 2022 Jul 1;40(19):2094-2105. doi: 10.1200/JCO.21.02496. Epub 2022 Mar 8. J Clin Oncol. 2022. PMID: 35258994 Free PMC article.
The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer.
Meadows-Taylor MB, Faris NR, Smeltzer MP, Ray MA, Fehnel C, Akinbobola O, Ariganjoye F, Patel A, Pacheco A, Mehrotra A, Fox R, Optican R, Tonkin K, Machin J, Wright J, Robbins ET, Osarogiagbon RU. Meadows-Taylor MB, et al. Among authors: akinbobola o. Chest. 2022 Jul;162(1):242-255. doi: 10.1016/j.chest.2022.01.046. Epub 2022 Feb 3. Chest. 2022. PMID: 35122751
Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis.
Smeltzer MP, Faris NR, Fehnel C, Akinbobola O, Saulsberry A, Meadows-Taylor M, Pacheco A, Ray M, Osarogiagbon RU. Smeltzer MP, et al. Among authors: akinbobola o. JTO Clin Res Rep. 2021 Mar 9;2(4):100161. doi: 10.1016/j.jtocrr.2021.100161. eCollection 2021 Apr. JTO Clin Res Rep. 2021. PMID: 34590011 Free PMC article.
16 results